FindTrial
Sign In

whole-body early cancer detection using 18F-FDG PET/MR combined with chest CT in asymptomatic subjects

The performance of 18F-FDG PET/MR combined with chest CT for whole-body early cancer detection in asymptomatic subjects

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060041
Enrollment
Unknown
Registered
2022-05-16
Start date
2016-04-30
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:whole-body 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance (18F-FDG PET/MR) combined with chest computerized tomography (CT)

Sponsors

Shanghai Universal Medical Imaging Diagnostic Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Asymptomatic healthy subjects who underwent PET/MR General examination and chest CT examination, some subjects (1210/3020) had blood tumor detection.

Exclusion criteria

Exclusion criteria: 1. Have a history of cancer or typical clinical manifestations of cancer; 2. Definite precancerous lesions, such as mucous leukoplakia, familial adenomatous polyposis, and cirrhosis; 3. Insufficient follow-up time or no further tests were performed during follow-up to determine whether there was a tumor.

Design outcomes

Primary

MeasureTime frame
detection rate of caners;specificity;sensitivity;—

Secondary

MeasureTime frame
positive predictive value and negative predictive value;—

Countries

China

Contacts

Public ContactGao Xin

Shanghai Universal Medical Imaging Diagnostic Center

gaoxin@uvclinic.cn+86 15901613704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026